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ABSTRACT
Cyclic neutropenia occurs due to the fluctuation of cellular 
production levels of bone marrow stem cells. This is to say, they 
change during the cycle, and although numbers are recurrently low, 
function is normal. Cyclic neutropenia was ſ rst described by Leale in 
1910 with dominant autosomal character. It manifests approximately 
every 21 days, with range of 14 to 36 days, lasting 3-6 days per 
episode. During the time when there are few circulating neutrophils, 
the patient is susceptible to infections. The clinical picture of this 
process includes: susceptibility to infection, feverish conditions, 
oral ulcers, impetigo, increased lymph nodes, periodontitis and 
stomatitis. It is important to stomatologically handle these patients; 
after inter-consultation with treating physician, prevent infection in a 
prophylactic scheme based on amoxicillin 50 mg/per kg weight or 
clindamycin 20 mg/per kg weight, review recent blood count results 
(maximum ten days before treatment). In emergency treatments 
pain and infection will be handled conservatively, with use of 
0.12% chlorhexidine mouthwashes and Philadelphia solution when 
necessary.
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RESUMEN
La neutropenia cíclica ocurre debido a que los niveles de producción 
celular por parte de las células madre de la médula ósea ƀ uctúan, 
es decir, cambian durante el ciclo; aunque el número es recurrente-
mente bajo, su función es normal. Fue descrita por primera vez por 
Leale en 1910, con carácter autosómico dominante. Se presenta 
aproximadamente cada 21 días con un rango de 14 a 36 días du-
rando un total de 3 a 6. Durante el periodo en el que existen pocos 
neutróſ los circulantes, el paciente es susceptible a las infecciones. 
Dentro del cuadro clínico se presentan: susceptibilidad a infeccio-
nes, cuadros febriles, fatiga, úlceras orales, impétigo, aumento de 
ganglios linfáticos, periodontitis, estomatitis. Es importante manejar 
estomatológicamente a estos pacientes, previa interconsulta con 
médico tratante, prevenir cuadros infecciosos bajo un esquema 
proſ láctico a base de amoxicilina 50 mg/kg peso o clindamicina 20 
mg/kg peso, revisar biometría hemática reciente (máximo 10 días 
previos al tratamiento); en tratamientos de urgencia se manejará de 
forma conservadora el dolor e infección, uso de enjuagues con clor-
hexidina al 0.12% y solución Philadelphia en caso de ser necesario.
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INTRODUCTION
Patients afflicted with cyclic neutropenia suffer 
periodic decreases of neutrophil numbers; this is an 
infrequent disorder and is characterized by habitual 
fever episodes.
Cyclic neutropenia occurs due to the ƀ uctuation of 
bone marrow stem cells’ cellular production, that is to 
say, a change during the cycle. Although the number 
is recurrently low, their function is normal.
Neutrophils are polymorphonuclear granulocytes, 
they approximately measure 8 to 12 micrometers, they 
are the most abundant leukocytes present in the blood, 
they live for 72 hours after having exited the bone 
marrow, and thus can be considered cells with the 
following characteristics: they are phagocytic, mobile 
cells, with gelatinous consistency; they can easily cross 
blood vessels as well as respond to inƀ ammation and 
infection stimuli ſ ve hours after initiation of process.
Therefore, neutropenia can be considered a 
signiſ cant decrease in the number of polymorphonuclear 
neutrophils per mm3 in peripheral blood. It is caused by 
alterations in cell production, excessive destruction of 
peripheral tissues, cell non-maturation or a disrupted 
cell distribution.1
These patients exhibit certain susceptibility to 
infections; therefore, neutropenia can be classiſ ed in 
the following manner:
a) Length: acute, chronic.
b) State of medullar reserve: preserved or low.
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c) Severity: mild, moderate or severe.
d) Nature or origin:
1) Acquired: medication:
• Anticonvulsant.
• Antihistaminic.
• Barbiturates.
• Chemo-therapeutic drugs.
• Diuretics.
• Sulfonamides/antibiotics.
2) Congenital:
• Kostmann disease.
• Shwachman syndrome.
• Cyclic neutropenia.
• Mielokatesis.
Cyclic neutropenia was ſ rst described by Leale in 
1910. He depicted it as a condition with autosomal 
dominant character, a result of the mutation of EIA2 
gene, position 13.3 of the short arm of chromosome 
19 which codiſ es neutrophil elastase. Its time span is 
occurrence within a rank of 14 to 36 days, normally 
around day 21, with duration of 3 to 6 days. It is more 
common for infections to appear during the period 
when there are few circulating neutrophils.2
There is an interruption in cell production of bone 
marrow stem cells. This can cause from normal 
production up to severe stagnation of neutrophil 
maturation. Pharmacological treatment of granulocyte 
colonies stimulating factor (G-CSF) promotes 
maturation of neutrophil-precursor cells.
Under normal circumstances, G-CSF is mainly 
produced in the bone marrow. When there is bacterial 
infection, G-CSF production increases due to the stimuli 
produced by certain components of the infectious 
agent on immune system cells. Final result is increase 
of neutrophil maturation in the bone marrow, greater 
release of said neutrophils into the bloodstream as well 
as activation of said cells functions, that is to say, their 
ability to destroy pathogen agents.
With respect to incidence it can be said that 
frequency is 2 cases per million subjects.3
The clinical picture might include the following 
manifestations: susceptibility to infections, fever, 
fatigue, impetigo, increase in the size of lymph nodes, 
periodontitis, cheilitis, stomatitis.
Diagnosis can be emitted when the following can 
be established: cyclic episodes of 200 total neutrophils 
per mm3, every three weeks for a period of 3 to 6 
days. To achieve conſ rmation, blood count must be 
performed 2 to 3 times a week, during 8 weeks.
Treatment is IV administration of «granulocyte 
colonies stimulation factor» (G-CSF), whose function, 
as indicated by its name, is to stimulate neutrophil 
production and shorten neutropenia duration, which 
brings along symptom’s decrease. In cases when 
the patient does not react favorably, bone marrow 
transplant or corticosteroids can be used.
When patients reach adolescence, they experiment 
symptom decrease and cycles become less noticeable.4
PROTOCOL FOR STOMATOGNATIC 
ASSESSMENT OF PATIENT WITH CYCLIC 
NEUTROPENIA CONDUCTED AT THE MEXICO’S 
CHILDREN’S HOSPITAL «FEDERICO GÓMEZ»
1) Condition identiſ cation, determination and detection 
of signs and symptoms characteristic of the 
condition.
2) Inter-consultation with treating pediatric hematologist 
concerning:
a) Actual status of the patient.
b) Recent blood counts (total neutrophil count).
c) Phase of neutropenic cycle which the patient is 
presently undergoing.
d) Type of pharmacological treatment used by the 
patient to control his neutropenic cycle.
3) Potential problems that can be encountered:
a) Formation of infectious processes.
b) Periodontitis.
c) Herpetic stomatitis.
d) Presence of acute pain.
e) Thrombocytopenia data when they are acquired 
by chemo-therapeutic drugs.
4) In order to avoid complications it is important to 
follow:
a) Anti-bacterial prophylactic scheme based on 
amoxicillin 50 mg/kg weight or clindamycin 
20/mg/kg weight in case of allergy so as to 
avoid infectious processes. It can be used as 
therapeutic scheme (every 8 hours for 7 days) 
whenever appointments are consecutive, or as 
a prophylactic scheme (1 hour before initiating 
dental treatment, single doses) whenever it is an 
emergency treatment or isolated appointments.
b) Revision of total number or neutrophils in 
blood counts conducted before and after dental 
treatment.
5) Modiſ cations to treatment plan:
a) When leukocyte count suddenly drops, antibiotics 
must be used in order to avoid post-operative 
infection.
6) Emergency treatments:
a) Avoid use of non steroid anti-inflammatory 
drugs, especially acetylsalicylic acid when 
there are thrombocytopenia data, nevertheless, 
paracetamol can be used.
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b) Use of Philadelphia solution when there is 
presence of stomatitis:
• Bismuth sub-salicylate 20 mL.
• Dyphenhydramine hydrochloride 10 mL.
• Sucralfate ½ tablet.
• Xylocaine 2 mL.
In 5 mL mouthwash rinses every 6 hours.
c) Use of palliative techniques for oral hygiene.
d) Use of .12% chlorhexidine rinses.
PERIODONTAL TREATMENT
Immuno-suppression is defined as the inhibition 
of one or more components of the immune system. 
It is the result of an underlying disease or it can be 
intentional through the use of drugs or treatments 
such as radiation. These patients are under greater 
risk of contracting infections, therefore, even minor 
periodontal infections can become life-threatening in 
cases when immune suppression is severe. Fungal, 
viral and bacterial intraoral infections might appear.
Treatment of these patients targets prevention of 
life-threatening oral complications. The greatest risk of 
infection occurs during extreme immune-suppression 
periods, therefore, treatment must be conservative 
and palliative.
Teeth with unfavorable diagnosis are extracted. 
Deep debridement of remnants is conducted so as 
to minimize bacterial load. Dental professionals must 
stress the importance of oral hygiene.7
In  order  to  avo id  secondary  in fec t ions , 8 
mouthwashes with antimicrobial agents such as .12% 
chlorhexidine are recommended, especially in patients 
showing mucositis.
BLOOD COUNT
When handling hematologic diseases, blood count 
is essential; it represents a diagnostic aid. Blood 
counts include: platelet, leukocyte, erythrocyte, 
hemoglobin and hematocrit counts as well as 
determining number, variety percentage concentration 
and quality of blood cells. It is therefore essential to 
know the normal values of each cell group so as to 
ascertain at which moment a safe and complication 
-free oral rehabilitation can be undertaken.
Data considered normal at the Mexico’s Children s 
Hospital «Federico Gómez» are the following:
Leucocytes 4-11 103/ȝL
Neutrophils 4.5-7.5%, 35-57 x 103/ȝL
Lymphocytes 1-4.8%, 25-45 x 103/ȝL
Monocytes 0.1-0.8%, 1-10 x 103/ȝL
Eosinophils 0.1-0.45%, 0-3 x 103/ȝL
Basophils 0-0.2%, 0-2 x 103/ȝL
Erythrocytes 3.92-6.2 x 103/ȝL
Hemoglobin 12-18 g/dL
Hematocrit 37-47%
Platelets 145-450 x 103/ȝL
When deal ing with pat ients suffer ing from 
hematologic disorders it is compulsory to know how 
NAN (neutrophil absolute number) can be obtained.
Leukocytes (103/ȝL) x neutrophils (%)
=
Total neutrophils
Therefore:
> Than 2,000 NAN x mm3 ---- patient can be treated 
without need to administer prophylactic antibiotics.
1,000 to 2,000 NAN x mm3 ---- prophylactic 
antibiotics must be administered for any type of dental 
procedure.
< 1,000 NAN x mm3 patients with severe immune-
suppression, must only be treated with palliative care.
In cases of thrombocytopenia, platelet replacement 
must be considered in cases when platelet count is 
lesser than 80.000 per mm3.5
CLINICAL CASE PRESENTATION
Female patient, 15 years old, weighing 30.200 kg 
and measuring 134 cm. Post-natal history revealed 
that patient suffered fetal distress, was in incubator 
for the first month of her life, was not breast-fed, 
and suffered speech problems as well a multiple 
respiratory infections during childhood.
Familial history revealed the following: 35 year old 
mother, apparently healthy, 6 year old brother, 34 year 
old father with history of cyclic neutropenia, maternal 
grandmother deceased due to dropsy.
The patient reported that she was admitted for the 
ſ rst time at the Mexico’s Children’s Hospital «Federico 
Gómez» in August 1994, due to a two-month evolution, 
persisting cough. A series of possible diagnoses were 
presented to the family. The list presented was the 
following:
• At 6 years of age, the patient was diagnosed with 
toxic neutropenia and speech disorders.
• At 7 years of age, a physiological murmur was 
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detected, with presence of peri-anal abscesses and 
mild anemia.
• At 8 years of age, chronic neutropenia data were 
observed.
• At 9 years, alongside the possible diagnosis 
of chronic neutropenia, signs of mild, non de-
compensated anemia were observed.
• At 10 years of age, real diagnosis is veriſ ed with the 
help of laboratory studies: 10 blood counts were taken 
every week taking special care of assessing total 
neutrophil numbers. In all executed blood counts, the 
patient exhibited an amount of neutrophil absolute 
numbers (NAN) which was below normal indexes 
(Table I). Clinically, it was additionally found that 
the patient suffered from urinary incontinence and 
2nd degree malnutrition. From that point onwards, 
the patient has been treated at the Hospital’s 
Hematology Department with «granulocyte colonies 
stimulating factor» (G-CSF), approximately every 
month to the present date, as long as her ſ nancial 
circumstances would allow it.
• At 15 years of age, the patient attended the Pediatric 
Stomatology Department having been referred 
by the Hematology Department of the Mexico’s 
Children’s Hospital «Federico Gómez». The 
patient’s mouth was clinically and radiographically 
examined, said examination revealed the following: 
generalized gingivitis associated to dental bioſ lm, 
periodontitis, soft tissues with suitable hydration, 
color and vascularization, appropriate frena 
implantation, symmetrical, continuous and whole 
alveolar processes, permanent dentition with dental 
malposition, presence of inter-dental spaces (Figure 
1), bone resorption (Figure 2) different degree caries 
in teeth number 17, 16, 15, 14, 24, 25, 26, 27, 37, 
36, 35, 46 and 47 (Figure 3), angular cheilitis, whitish 
lesions in progression, recording high caries risk 
index according to Tinanoff’s6 assessment criteria.
I n t e r - consu l t a t i on  w i t h  t he  Hema to l ogy 
Department was undertaken. Due to the presence 
of pain experienced by the patient, it was decided 
to simultaneously conduct hematological and 
stomatological treatments.
Therefore, a series of 7 blood counts (hematic 
biometry) was programmed, they should be taken from 
one day before rehabilitation initiation up to two days 
after completing it, so as to assess total neutrophil 
counts.
Drug selected by the Hematology Department was 
administered 48 hours before oral treatment (Figure 
4). The first blood count revealed neutropenia data 
(460 total neutrophil). For this reason it was decided to 
initiate oral rehabilitation on the next day.
The next day a new blood count was taken which 
revealed 4200 total neutrophil, therefore, it was 
decided to initiate dental treatment. This treatment 
was divided into three phases:
• Phase I: hygiene preventive program: preventive 
hygiene measures were taken such as plaque 
control, brushing after all meals, with toothpaste 
containing 1,000 to 1,500 ppm fluoride, topical 
applications every 3 months since the patient was 
considered at high risk to suffer caries (modified 
Stillman technique). Use of dental floss was 
implemented as well as scheduled meals, decrease 
of carbohydrates and reſ ned sugars ingestion, as 
well as avoiding snacks between meals.
• Phase II: restorative therapy: white lesions were 
monitored, cavity and progress lesions were 
restored. An aggressive treatment was followed to 
minimize caries progression, using 2% lidocaine 
with epinephrine as the dose recommended by Dr. 
Stanley Malamed’s in «Clinical action of specific 
agents. Handbook of local anesthesia» (4.4 mg/
kg) administering total dose of 36 mg at every 
appointment.6
Table I. Series of blood counts (9) which revealed data of 
cyclic neutropenia. 
Weeks June July August
1 ------------- 350 NAN 697 NAN
2 ------------- 580 NAN 243 NAN
3 220 NAN 270 NAN 190 NAN
4 132 NAN 186 NAN --------------
NAN = number of total neutrophils. Figure 1. Pre-operative clinical picture.
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 Thus, oral rehabilitation consisted on amalgam 
ſ llings in teeth 17, 16, 15, 14, 24, 25, 26, 27, 37, 
35, 47, as well as extraction of teeth 46 and 36. 
With behavior handling techniques, the most 
recent notes of the Hematology Department 
were consulted, personally inter-consulting with 
the treating pediatric hematologist. Review of 
daily blood count results (total neutrophil count), 
assessment of «granulocyte colonies stimulation 
factor (G-CSF)» applied at the Hematologic 
Department, as well as oral hygiene care and use 
of chlohexidine mouthwash. On extraction day anti-
bacterial prophylaxis was prescribed, amoxicillin, 
50 mg/kg one hour before treatment initiation so 
as to avoid formation of infectious processes or 
any other post-operative complication. The full 
restorative procedure was completed in three short 
appointments (Figures 5 and 6).
• Phase III: multi-disciplinary care: additionally 
to being in constant communication with the 
Hematology Department, the case was also treated 
within the Periodontics Department so as to control 
infectious processes and implement suitable oral 
hygiene techniques.
 The Hospital’s Nutrition Department contributed 
with dietary advice.
CONCLUSIONS
Hematologic disorders represent one of the most 
interesting problems to be considered by the dentist 
in his everyday practice. Susceptibility to infectious 
processes makes them a special group to be 
carefully considered in order to avoid post-operative 
complications. Research of an hematologic disorder 
requires careful laboratory and clinical studies.
According to scientiſ c literature, there are two types 
of leukocyte disorders: leukocytosis and leukopenia, 
which compromise the body’s defense system.
There are additionally many other causes for the 
decrease of leukocytes (4-11 mm3) in the blood. A 
patient afƀ icted with severe leukopenia is susceptible 
to infections and periodontal disease. These potential 
problems can become severe when related to dental 
Figure 2. 
Bone resorption. Periodontitis 
data.
Figure 3. 
Clinical pictures of upper arch 
(A), lower arch (B) without oral 
rehabilitation.
A B
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treatment. In order to avoid these complications, it 
is important to possess a serial count of white blood 
cells, and thus, select the appropriate moment in 
the cycle when the count is very close to normal. It 
is additionally important to know how to prescribe 
antibiotic prophylaxis in necessary cases.
Pediatric stomatologists, as members of the 
multi-disciplinary team in the treatment of medically 
compromised patients, must understand the protocol 
care for children with hematological alterations, in this 
case, white blood cells:
1) Identify the disease and its signs and symptoms.
2) Inter-consult with treating hematologist to ascertain 
the patient’s comprehensive current circumstances.
3) Identify potential problems which might occur 
before, during or after treatment.
4) Determine antibacterial prophylactic regime.
5) Review total neutrophil numbers in blood counts 
taken before, during and after dental treatment.
6) If there are emergency treatments to be undertaken, 
when the patient is at the lowest stage of total 
neutrophil count in his cycle, use of acetylsalicylic 
acid and non steroid anti-inƀ ammatory drugs must 
be avoided, since the patient will probably exhibit 
evidence of thrombocytopenia . Nevertheless, 
paracetamol (with or without codein) can be 
used palliatively as well as Philadelphia solution 
or chlorhexidine rinses during the patient’s oral 
hygiene technique until circumstances improve.
When following step-by-step the stomatological 
handling of patients with hematologic disorders, we 
Figure 5. 
Clinical picture of upper arch 
(A), and lower arch (B) with oral 
rehabilitation.A B
Figure 6. 
Clinical picture: right lateral 
clinical picture (A) and left lateral 
clinical picture (B) with oral 
rehabilitation.A B
Figure 4. Filgrastim. Colonies stimulating factor; helps the 
body to produce neutrophils.
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decided to treat with all confidence the 15 year old 
female patient. It is worth mentioning that, in spite of 
counting with guides in literature such as assessing 
the patient’s present circumstances, possessing a 
recent blood count as well as prophylactic antibiotic 
scheme, in the present case there were a series of 
hematological alterations, which caused delay in the 
oral rehabilitation process. Once the patient’s total 
neutrophil count was controlled, it was decided to 
continue treatment. Satisfactory results were thus 
obtained, and, what is more important, the patient’s 
life was not compromised.
A comprehensive, safe, and complication-free 
rehabilitation will be achieved when clinicians can 
identify emergency oral treatments and are able 
to solve them as part of a multi-disciplinary team, 
especially with a hematologic specialist.
It is important to bear in mind that these patients 
have received poor oral and dental care, since 
there are no speciſ c prevention guides or protection 
programs. Post-operative control as well as follow-up 
appointments are extremely important to maintain the 
patient under control.
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